Back to Browse Journals » Risk Management and Healthcare Policy » Volume 3

Impact of “noncaloric” activity-related factors on the predisposition to obesity in children

Authors Angelo Tremblay, Émilie Pérusse-Lachance, Patrice Brassard

Published 5 July 2010 Volume 2010:3 Pages 27—32

DOI https://dx.doi.org/10.2147/RMHP.S7986

Review by Single-blind

Peer reviewer comments 3

Angelo Tremblay, Émilie Pérusse-Lachance, Patrice Brassard

Division de Kinésiologie, PEPS, Université Laval and Centre de Recherche de l’Institut Universitaire en Cardiologie et Pneumologie de Québec, Québec, Canada

Abstract: The research related to childhood obesity generally emphasizes the impact of unhealthy eating and sedentary behavior as the main determinants of the predisposition to the positive energy balance that underlies excess body fat accumulation. Recent investigations have, however, demonstrated that “noncaloric” activity-related factors can induce a significant imbalance between spontaneous energy intake and energy expenditure. This is the case for short sleep duration that favors hormonal changes that increase hunger and energy intake. This agrees with our research experience demonstrating that short sleeping predicts the risk of obesity in children to a greater extent than sedentary behavior. Recent research by our team has also showed that demanding mental work promotes a substantial increase in energy intake without altering energy expenditure. In addition, our preliminary data suggest that the regular practice of school-related cognitive efforts is predictive of an increase in abdominal fat accumulation. As discussed in this paper, individual variations in brain oxygenation and its related cerebral aerobic fitness might play a role in the relationship between mental work, energy intake, and the risk of excess body weight.

Keywords: sleep duration, mental work, brain oxygenation, energy intake, energy expenditure

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads

Schroyen S, Adam S, Jerusalem G, Missotten P

Clinical Interventions in Aging 2015, 10:117-125

Published Date: 31 December 2014

Brachytherapy in the treatment of cervical cancer: a review

Banerjee R, Kamrava M

International Journal of Women's Health 2014, 6:555-564

Published Date: 28 May 2014

Clinical epidemiology of epithelial ovarian cancer in the UK

Doufekas K, Olaitan A

International Journal of Women's Health 2014, 6:537-545

Published Date: 23 May 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients

Yee AJ, Raje NS

Clinical Interventions in Aging 2012, 7:331-338

Published Date: 3 September 2012

Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer

Takeda M, Okamoto I, Nishimura Y, Nakagawa K

Lung Cancer: Targets and Therapy 2011, 2:59-67

Published Date: 14 October 2011

Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs

Rao S, Song Y, Peddie F, Evans AM

International Journal of Nanomedicine 2011, 6:1245-1251

Published Date: 20 June 2011

Use of electronic medical records in oncology outcomes research

Gena Kanas, Libby Morimoto, Fionna Mowat, et al

ClinicoEconomics and Outcomes Research 2010, 2:1-14

Published Date: 24 February 2010